BIIB
NASDAQ · Biotechnology
Biogen Inc
$227.53
+2.17 (+0.96%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+65.27%
YTD
+27.96%
Open$226.94
Previous Close$225.36
Day High$229.19
Day Low$222.36
52W High$225.80
52W Low$135.39
Volume—
Avg Volume717.0K
Market Cap32.37B
P/E Ratio38.78
EPS$5.65
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$179.51
Above
SMA 200
$150.33
Above
RSI (14)
64.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
43 analysts
Price Target
-59.8% upside
Current
$227.53
$227.53
Target
$91.45
$91.45
$57.23
$91.45 avg
$114.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.10B | 10.19B | 3.09B |
| Net Income | 1.32B | 1.20B | 745.08M |
| Profit Margin | 13.1% | 12.4% | 24.1% |
| EBITDA | 2.28B | 2.18B | 1.15B |
| Free Cash Flow | — | — | 775.19M |
| Rev Growth | -0.9% | -0.9% | +20.7% |
| Debt/Equity | 0.34 | 0.34 | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.08 | -0.05% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.09 | -1.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.37 | -0.85% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $516.34 | +0.26% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $801.82 | -0.26% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.51 | -2.04% | 40.0 | 32.33B |